论文部分内容阅读
目的探讨阿魏酸钠联合奥扎格雷钠治疗脑梗死患者的临床疗效。方法选取2014年7月至2015年7月河北省保定市民安依棉医院所收治的90例脑梗死患者作为研究对象,按随机数字表法将其分为对照组和试验组,每组45例。对照组患者采用奥扎格雷钠进行治疗,试验组患者在对照组基础上给予阿魏酸钠。比较两组患者的临床治疗效果、神经功能缺损情况。结果试验组患者治疗的总有效率明显高于对照组,差异有统计学意义(P<0.05);治疗后,两组患者的美国国立卫生研究院卒中量表(NIHSS)评分均明显低于治疗前,且试验组患者的NIHSS评分显著低于对照组,差异均有统计学意义(均P<0.05)。结论阿魏酸钠联合奥扎格雷钠治疗脑梗死患者临床疗效明显,可有效改善患者神经功能。
Objective To investigate the clinical effect of sodium ferulate combined with ozagrel on patients with cerebral infarction. Methods From July 2014 to July 2015, 90 patients with cerebral infarction admitted by Anyang Cotton Hospital of Baoding City, Hebei Province were selected as the research objects. According to the random number table, they were divided into control group and experimental group, with 45 cases in each group . Patients in the control group were treated with ozagrel sodium, and patients in the test group were given sodium ferulate on the basis of the control group. The clinical effects and neurological deficits of the two groups were compared. Results The total effective rate of the treatment group was significantly higher than that of the control group (P <0.05). After treatment, the NIHSS scores of both groups were significantly lower than those of the treatment group The NIHSS scores in the experimental group were significantly lower than those in the control group (all P <0.05). Conclusion Sodium ferulate combined with ozagrel sodium has obvious curative effect on patients with cerebral infarction, which can effectively improve the neurological function.